NOV 05, 2020 9:00 AM PST

Panel Presentation: The NIH HEAL Initiative: A Bold Interagency Response to the Opioid Crisis

Presented at: Opioid Crisis 2020
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Director, NIH HEAL Initiative, Office of the Director, National Institutes of Health
    Biography

      Rebecca G. Baker, Ph.D., is the director of the Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM, in the Office of the Director, NIH. Dr. Baker helped develop the NIH HEAL Initiative and leads coordination of HEAL programmatic activities between the Office of the Director and relevant Institutes and Centers (ICs), NIH HEAL Initiative staff, and governance committees. She also provides expert advice to and represents the NIH Director on initiative-related activities, including interagency efforts and partnerships in pain and opioid research and policy. Prior to holding this position, Dr. Baker was special assistant to the NIH Director, working directly with NIH leadership to develop new scientific initiatives, and analyze scientific, legislative, communications, and policy issues. Previously, she worked as a postdoctoral scientist using next-generation DNA sequencing to identify novel disease-causing genes in patients with rare immunological diseases. She earned her Ph.D. from the University of Pennsylvania and her bachelor's degree from Cornell University.

    • Director, Office of Pain Policy, National Institute of Neurological Disorders and Stroke
      Biography

        Dr. Linda Porter directs the National Institutes of Health’s Office of Pain Policy and Planning. She holds a bachelor’s degree in Physical Therapy from McGill University and a Ph.D. in Neuroscience from Boston University. Dr. Porter trained in neurophysiology at Rockefeller University and then served on the   faculty of the Uniformed Services University, where she directed a research program on sensory-motor integration. Dr. Porter joined the NIH in 2003 where her role includes coordinating activities of the NIH Pain Consortium and the Interagency Pain Research Coordinating Committee, whose missions respectively, are to advance the trans-NIH and interagency pain research agenda. She co-chaired the development of the National Pain Strategy and the Federal Pain Research Strategy and now is involved with the NIH HEAL (Helping End Addiction Long-term) initiative. Dr. Porter has been recognized for her work through the President’s Award from the American Academy of Pain Management, NIH Director’s Awards, and the Emma and John Bonica Public Service Award from the American Pain Society.

      • Director, Office of Science Policy and Communications; Chief of Staff, National Institute on Drug Abuse
        Biography

          Jack B. Stein, Ph.D. has over two decades of professional experience in leading national drug and HIV-related research, practice, and policy. He first joined NIDA as the OSPC Deputy Director, and later as the Deputy Director for the Division of Epidemiology, Services and Prevention Research. He then left NIDA to become Director of the Division of Services Improvement, Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Services Administration. Immediately prior to rejoining NIDA, Dr. Stein served as the Chief of the Prevention Branch, Office of Demand Reduction, at the White House Office of National Drug Control Policy. Dr. Stein has authored numerous articles, book chapters, and reports on HIV prevention and substance use services. He is a graduate of Union College, where he earned a bachelor of science in biology. He holds a master’s degree in social work from New York University and a doctoral degree in health services from Walden University.


        Abstract

        More than 50,700 Americans died of opioid overdose in 2019, and more than 1.6 million Americans live with addiction to opioids. Moreover, more than 50 million Americans suffer from chronic pain, and of those, 25 million live with daily chronic pain and lack effective and safe non-opioid options for pain management.  The Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM, is a trans-NIH research effort focused on improving prevention and treatment for opioid misuse and addiction and enhancing pain management. This presentation will describe the purpose of the NIH HEAL Initiative and describe how it is organized and being implemented utilizing a collaborative, multi-disciplinary approach. An update on progress to date and future plans will also be addressed.

        Learning Objectives:

        1. Understand the extent of the U.S. opioid epidemic and how widespread use of prescription opioids and the lack of effective pain treatment fueled the crisis

        2. Explain what the NIH HEAL Initiative is and how it is addressing unmet research needs to curb the opioid crisis

        3. Describe the six major research priority areas that make up the NIH HEAL Initiative


        Show Resources
        You May Also Like
        FEB 24, 2021 10:00 AM PST
        C.E. CREDITS
        FEB 24, 2021 10:00 AM PST
        DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
        DEC 03, 2020 4:30 PM PST
        C.E. CREDITS
        DEC 03, 2020 4:30 PM PST
        This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
        JAN 21, 2021 8:00 AM PST
        JAN 21, 2021 8:00 AM PST
        Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
        NOV 18, 2020 8:00 AM PST
        C.E. CREDITS
        NOV 18, 2020 8:00 AM PST
        DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
        NOV 05, 2020 7:00 AM PST
        C.E. CREDITS
        NOV 05, 2020 7:00 AM PST
        DATE: Date needed, 2020 TIME: Time needed Exosomes are a population of naturally occurring mobile, membrane-limited, 30 – 100 nm in diameter, extracellular vesicles containing a large...
        OCT 29, 2020 6:00 AM PDT
        C.E. CREDITS
        OCT 29, 2020 6:00 AM PDT
        Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
        Loading Comments...
        Show Resources